INSPIRE PHARMACEUTICALS INC - FORM 10-K - EX-23.1 - ACCOUNTANT'S CONSENT - March 15, 2010

Attached files

file filename
10-K - FORM 10-K - INSPIRE PHARMACEUTICALS INCd10k.htm
EX-31.1 - CERTIFICATION - INSPIRE PHARMACEUTICALS INCdex311.htm
EX-32.1 - CERTIFICATION - INSPIRE PHARMACEUTICALS INCdex321.htm
EX-32.2 - CERTIFICATION - INSPIRE PHARMACEUTICALS INCdex322.htm
EX-31.2 - CERTIFICATION - INSPIRE PHARMACEUTICALS INCdex312.htm
EX-10.53 - EXECUTIVE INCENTIVE COMPENSATION RECOVERY POLICY - INSPIRE PHARMACEUTICALS INCdex1053.htm
EX-10.55 - AMENDED AND RESTATED DIRECTOR COMPENSATION POLICY - INSPIRE PHARMACEUTICALS INCdex1055.htm
EX-10.54 - AMENDED AND RESTATED EQUITY COMPENSATION GRANT POLICY - INSPIRE PHARMACEUTICALS INCdex1054.htm

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-147733 and 333-141169) and Form S-8 (Nos. 333-56360, 333-130496 and 333-148185) of Inspire Pharmaceuticals, Inc. of our report dated March 15, 2010 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.

 

/s/ PricewaterhouseCoopers LLP

Raleigh, North Carolina
March 15, 2010

INSPIRE PHARMACEUTICALS INC Reports